6-Hydroxyindazole

Catalog No.: 
ACYFMS305
CAS No.: 
23244-88-4
Molecular Formula: 
C7H6N2O
Molecular Weight: 
134.14
6-Hydroxyindazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$65.00In stockInquiry
10g98%$106.00In stockInquiry
25g98%$247.00In stockInquiry
100g98%$986.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Hydroxyindazole
IUPAC Name1H-indazol-6-ol
MDL No.MFCD00022788
Molecular FormulaC7H6N2O
Molecular Weight134.14
SMILESOC1=CC2=C(C=C1)C=NN2
InChI KeyNUYZVDBIVNOTSC-UHFFFAOYSA-N
Synonym6-Hydroxy-1H-indazole | INDAZOL-6-OL | 6-Isoindazolol | C19504 | SCHEMBL177086 | DTXSID70901318 | NoName_418 | Ethanaminium, N-[9-(2-carboxyphenyl)-6-(diethylamino)-3H-xanthen-3-ylidene]-N-ethyl-, chloride | Indazole, 6-hydroxy- | starbld0007539 | NCGC000
CAS No.23244-88-4
PubChem CID135483987

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACYFMS305 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZPIW048 route compound structure diagram
    ACZPIW0483522-07-4In Stock
  2. Then
  3. ACYFMS305 route product structure diagram
    ACYFMS30523244-88-4In Stock
Inquiry

2. ACYFMS305 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYHNQ728 route compound structure diagram
    ACYHNQ7286967-12-0In Stock
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7In Stock
  4. Then
  5. ACYFMS305 route product structure diagram
    ACYFMS30523244-88-4In Stock
Inquiry

3. ACYFMS305 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYHNQ728 route compound structure diagram
    ACYHNQ7286967-12-0In Stock
  2. Then
  3. ACYFMS305 route product structure diagram
    ACYFMS30523244-88-4In Stock
Inquiry

Comments (0)